modified version of RPI-78M (Nutra Pharma)

N/A

Report date: 2025/03/20 15:18:44

Base Information

Drug Namemodified version of RPI-78M (Nutra Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNutra Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNutra Pharma
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A